Menu
GeneBe

rs776535574

Variant summary

Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong

The NM_001352514.2(HLCS):ā€‹c.2432A>Gā€‹(p.Tyr811Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000967 in 1,603,438 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…ā˜…). Synonymous variant affecting the same amino acid position (i.e. Y811Y) has been classified as Likely benign.

Frequency

Genomes: š‘“ 0.000093 ( 0 hom., cov: 31)
Exomes š‘“: 0.000097 ( 0 hom. )

Consequence

HLCS
NM_001352514.2 missense

Scores

7
8
1

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 7.33
Variant links:
Genes affected
HLCS (HGNC:4976): (holocarboxylase synthetase) This gene encodes an enzyme that catalyzes the binding of biotin to carboxylases and histones. The protein plays an important role in gluconeogenesis, fatty acid synthesis and branched chain amino acid catabolism. Defects in this gene are the cause of holocarboxylase synthetase deficiency. Multiple alternatively spliced variants, encoding the same protein, have been identified.[provided by RefSeq, Jun 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 6 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.964

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
HLCSNM_001352514.2 linkuse as main transcriptc.2432A>G p.Tyr811Cys missense_variant 10/11 ENST00000674895.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HLCSENST00000674895.3 linkuse as main transcriptc.2432A>G p.Tyr811Cys missense_variant 10/11 NM_001352514.2 P4P50747-2

Frequencies

GnomAD3 genomes
AF:
0.0000933
AC:
14
AN:
150036
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000493
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000197
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000148
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000127
AC:
32
AN:
251492
Hom.:
0
AF XY:
0.000155
AC XY:
21
AN XY:
135920
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000508
Gnomad NFE exome
AF:
0.000123
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000970
AC:
141
AN:
1453402
Hom.:
0
Cov.:
33
AF XY:
0.000108
AC XY:
78
AN XY:
722932
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000135
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000511
Gnomad4 NFE exome
AF:
0.0000913
Gnomad4 OTH exome
AF:
0.000100
GnomAD4 genome
AF:
0.0000933
AC:
14
AN:
150036
Hom.:
0
Cov.:
31
AF XY:
0.000109
AC XY:
8
AN XY:
73170
show subpopulations
Gnomad4 AFR
AF:
0.0000493
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000197
Gnomad4 NFE
AF:
0.000148
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000154
Hom.:
0
Bravo
AF:
0.0000718
ExAC
AF:
0.0000906
AC:
11
EpiCase
AF:
0.000109
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Holocarboxylase synthetase deficiency Uncertain:3
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Jan 24, 2020- -
Uncertain significance, criteria provided, single submitterclinical testingInvitaeAug 12, 2022This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 664 of the HLCS protein (p.Tyr664Cys). This variant is present in population databases (rs776535574, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with HLCS-related conditions. ClinVar contains an entry for this variant (Variation ID: 339957). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt HLCS protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 15, 2022The c.1991A>G (p.Y664C) alteration is located in exon 11 (coding exon 8) of the HLCS gene. This alteration results from a A to G substitution at nucleotide position 1991, causing the tyrosine (Y) at amino acid position 664 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxNov 15, 2023In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.39
BayesDel_addAF
Pathogenic
0.28
D
BayesDel_noAF
Pathogenic
0.45
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.69
D;D;D
Eigen
Pathogenic
0.73
Eigen_PC
Uncertain
0.61
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.93
D;.;.
M_CAP
Pathogenic
0.50
D
MetaRNN
Pathogenic
0.96
D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.7
H;H;H
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.67
T
Sift4G
Uncertain
0.0070
D;D;D
Polyphen
1.0
D;D;D
Vest4
0.96
MVP
0.99
MPC
0.65
ClinPred
0.95
D
GERP RS
4.7
Varity_R
0.89
gMVP
0.83

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs776535574; hg19: chr21-38128861; API